BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 35273384)

  • 1. Circulating tumour cells in the -omics era: how far are we from achieving the 'singularity'?
    Visal TH; den Hollander P; Cristofanilli M; Mani SA
    Br J Cancer; 2022 Jul; 127(2):173-184. PubMed ID: 35273384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling circulating tumour cells and other biomarkers of invasive cancers.
    Poudineh M; Sargent EH; Pantel K; Kelley SO
    Nat Biomed Eng; 2018 Feb; 2(2):72-84. PubMed ID: 31015625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
    Morrison GJ; Goldkorn A
    Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
    Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
    Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic technologies for circulating tumour cells and exosomes.
    Shao H; Chung J; Issadore D
    Biosci Rep; 2015 Nov; 36(1):e00292. PubMed ID: 26604322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
    Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
    Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell omics: a new perspective for early detection of pancreatic cancer?
    Wang Q; Šabanović B; Awada A; Reina C; Aicher A; Tang J; Heeschen C
    Eur J Cancer; 2023 Sep; 190():112940. PubMed ID: 37413845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
    Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
    Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumour Cells in Lung Cancer.
    Chemi F; Mohan S; Brady G
    Recent Results Cancer Res; 2020; 215():105-125. PubMed ID: 31605226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer.
    Hou J; Guo C; Lyu G
    Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies.
    Debattista J; Grech L; Scerri C; Grech G
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology and clinical potential of circulating tumor cells.
    Lozar T; Gersak K; Cemazar M; Kuhar CG; Jesenko T
    Radiol Oncol; 2019 May; 53(2):131-147. PubMed ID: 31104002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumour cell isolation, analysis and clinical application.
    Zhang X; Xie P; Zhang K; Zhang W
    Cell Oncol (Dordr); 2023 Jun; 46(3):533-544. PubMed ID: 36658417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers.
    Khan T; Becker TM; Po JW; Chua W; Ma Y
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better together: circulating tumor cell clustering in metastatic cancer.
    Schuster E; Taftaf R; Reduzzi C; Albert MK; Romero-Calvo I; Liu H
    Trends Cancer; 2021 Nov; 7(11):1020-1032. PubMed ID: 34481763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size-based separation methods of circulating tumor cells.
    Hao SJ; Wan Y; Xia YQ; Zou X; Zheng SY
    Adv Drug Deliv Rev; 2018 Feb; 125():3-20. PubMed ID: 29326054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study.
    Salvianti F; Gelmini S; Mancini I; Pazzagli M; Pillozzi S; Giommoni E; Brugia M; Di Costanzo F; Galardi F; De Luca F; Castiglione F; Messerini L; Pinzani P; Antonuzzo L
    Br J Cancer; 2021 Jul; 125(1):94-100. PubMed ID: 33953347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential clinical utility of liquid biopsies in ovarian cancer.
    Zhu JW; Charkhchi P; Akbari MR
    Mol Cancer; 2022 May; 21(1):114. PubMed ID: 35545786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.